Skip links
Companies
› Switzerland › Adc Therapeutics Sa
Company registry profile
Adc Therapeutics Sa logo

Adc Therapeutics Sa

Private limited company (Ltd.) Active

in

From the registry

Registration details

Registration No.
CHE461408645
Incorporation Date
2011-06-06
Address
Epalinges, Switzerland
Website
www.adctherapeutics.com/
Status
Active
Country
Switzerland
Source: Zefix — Swiss Central Business Names IndexRegistry coverage
Registry summary

Company overview

Adc Therapeutics Sa is a Private limited company (Ltd.) registered in Switzerland under CHE461408645, and its current status with Zefix — Swiss Central Business Names Index is active. The company was incorporated on 6 June 2011 and lists its registered address as Epalinges, Switzerland. 3 shareholders are on record for Adc Therapeutics Sa, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Zefix — Swiss Central Business Names Index and was last updated on 28 September 2026.

Data Provenance
This record is sourced directly from official government registries, including Zefix — Swiss Central Business Names Index.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

3

Shareholders of Adc Therapeutics Sa

Three shareholders are currently on record for Adc Therapeutics Sa, reflecting the Aktienbuch (share register) maintained under Article 686 of the Swiss Code of Obligations rather than a public filing. The largest of these is Fidelity Salem Street Trust-Fidelity Small Cap Index Fund, holding 1.3% — the largest recorded stake — followed by VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund at 0.6%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Data-provider feed — rows as supplied to Zavia for Zefix — Swiss Central Business Names Index, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.

Swipe or scroll for more columns

Shareholder Type Holding Source Document
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund 1.3% Zefix — Swiss Central Business Names Index
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund 0.6% Zefix — Swiss Central Business Names Index

Officers

5

Directors and officers of Adc Therapeutics Sa

The Investor Relations Officer of Adc Therapeutics Sa currently on record is Amanda Hamilton; five officers are currently on record for Adc Therapeutics Sa, filed with Zefix — Swiss Central Business Names Index. Management authority at Adc Therapeutics Sa sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

Data availability

The register reports 14 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Data-provider feed — rows as supplied to Zavia for Zefix — Swiss Central Business Names Index, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.

AH
Amanda Hamilton ACTIVE

Residence
🇨🇭 Switzerland
Occupation
Investor Relations Officer

KH
Kristen Harrington-smith ACTIVE

Residence
🇨🇭 Switzerland
Occupation
Chief Commercial Officer

MZ
Mohamed Zaki M.d., Ph.d. ACTIVE

Residence
🇨🇭 Switzerland
Occupation
Chief Medical Officer

NR
Nicole Riley ACTIVE

Residence
🇨🇭 Switzerland
Occupation
Head Of Investor Relations & Corporate Communications

PJ
Peter J. Graham Esq. ACTIVE

Residence
🇨🇭 Switzerland
Occupation
Secretary & Chief Legal Officer

Group Structure

Group structure of Adc Therapeutics Sa

Adc Therapeutics Sa has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 3 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

  • ADC THERAPEUTICS (UK) LIMITED (United Kingdom)
  • ADC Therapeutics America, Inc. (United States)

Data availability

Those 2 subsidiaries span Switzerland, United Kingdom, United States jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Data-provider feed — rows as supplied to Zavia for Zefix — Swiss Central Business Names Index, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.

Top of recorded group
Adc Therapeutics Sa
Switzerland
ADC THERAPEUTICS (UK) LIMITED
United KingdomGB 09353055

ADC Therapeutics America, Inc.
United StatesUS NJ 5654914

Registry questions

Frequently asked questions

Who owns Adc Therapeutics Sa?

Three shareholders are currently on record for Adc Therapeutics Sa, reflecting the Aktienbuch (share register) maintained under Article 686 of the Swiss Code of Obligations rather than a public filing. The largest of these is Fidelity Salem Street Trust-Fidelity Small Cap Index Fund, holding 1.3% — the largest recorded stake — followed by VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund at 0.6%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is Adc Therapeutics Sa's UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for Adc Therapeutics Sa is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does Adc Therapeutics Sa have on record?

3 shareholders are shown on record for Adc Therapeutics Sa.

What is Adc Therapeutics Sa's company registration number?

Adc Therapeutics Sa's registration number is CHE461408645, filed with Zefix — Swiss Central Business Names Index in Switzerland. Its current status on the register is active.

Is Adc Therapeutics Sa still an active company?

Adc Therapeutics Sa's status on Zefix — Swiss Central Business Names Index is listed as active.

When was Adc Therapeutics Sa incorporated?

Adc Therapeutics Sa was incorporated on 6 June 2011, according to Zefix — Swiss Central Business Names Index.

What is Adc Therapeutics Sa's registered address?

The registered address on file for Adc Therapeutics Sa is Epalinges, Switzerland.

What legal structure is Adc Therapeutics Sa registered as?

Adc Therapeutics Sa is registered as a Private limited company (Ltd.) in Switzerland.

Who are the officers/directors of Adc Therapeutics Sa?

The Investor Relations Officer of Adc Therapeutics Sa currently on record is Amanda Hamilton; five officers are currently on record for Adc Therapeutics Sa, filed with Zefix — Swiss Central Business Names Index. Management authority at Adc Therapeutics Sa sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does Adc Therapeutics Sa have a parent company or subsidiaries?

Adc Therapeutics Sa has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 3 jurisdictions. Those 2 subsidiaries span Switzerland, United Kingdom, United States jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Other companies in Switzerland · Healthcare

All companies in Switzerland · Human Health and Social Work Activities in Switzerland

This website uses cookies to improve your web experience.